EP3263566 - BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AS ALLOSTERIC MODULATORS OF THE METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5 OR MGLUR5) FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.11.2018 Database last updated on 03.09.2024 | |
Former | Request for examination was made Status updated on 06.07.2018 | ||
Former | The application has been published Status updated on 01.12.2017 | Most recent event Tooltip | 30.11.2018 | Application deemed to be withdrawn | published on 02.01.2019 [2019/01] | Applicant(s) | For all designated states H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | [2018/01] | Inventor(s) | 01 /
LI, Guiying 76 Rutgers Place, Apt. No. 1 River Edge, NJ 07661 / US | 02 /
ZHOU, Hao 325 Edstan Way Paramus, NJ 07652 / US | 03 /
WEISS, Jesse 169 South Park Drive Woodbridge, NJ 07095 / US | 04 /
DOLLER, Dario 15 Quarterhorse Crossing Sparta, NJ 07871 / US | 05 /
BURNS, James, Ford 11 Madison Street Glen Ridge, NJ 07028 / US | [2018/01] | Application number, filing date | 17178046.3 | 22.12.2011 | [2018/01] | Priority number, date | US201061426379P | 22.12.2010 Original published format: US 201061426379 P | [2018/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3263566 | Date: | 03.01.2018 | Language: | EN | [2018/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.10.2017 | Classification | IPC: | C07D401/12 | [2018/01] | CPC: |
C07D417/12 (EP,CN,US);
C07D401/12 (EP,CN,KR,US);
C07D213/81 (EP,CN,US);
A01N43/40 (KR);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
C07D213/75 (EP,US);
C07D213/82 (EP,US);
C07D239/28 (EP,US);
C07D239/42 (EP,US);
C07D241/20 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/32] |
Former [2018/01] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 03.07.2018 | ME | 03.07.2018 | Title | German: | BICYCLO[3.2.1]OCTYLAMID-DERIVATE ALS ALLOSTERISCHE MODULATOREN DES METABOTROPISCHEN GLUTAMAT-REZEPTORS 5 (MGLU5 ODER MGLUR5) ZUR BEHANDLUNG VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS (ZNS) | [2018/01] | English: | BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AS ALLOSTERIC MODULATORS OF THE METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5 OR MGLUR5) FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS | [2018/01] | French: | DÉRIVÉS D'AMIDE BICYCLO[3.2.1]OCTYL EN TANT QUE MODULATEURS ALLOSTERIQUES DU RÉCEPTEUR 5 MÉTABOTROPIQUE DU GLUTAMATE (MGLU5 OU GLUR5) POUR LE TRAITEMENT DES TROUBLES DU SYSTÈME NERVEUX CENTRAL (SNC) | [2018/01] | Examination procedure | 27.06.2017 | Date on which the examining division has become responsible | 03.07.2018 | Examination requested [2018/32] | 04.07.2018 | Application deemed to be withdrawn, date of legal effect [2019/01] | 16.08.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2019/01] | Parent application(s) Tooltip | EP11852103.8 / EP2654422 | Fees paid | Renewal fee | 27.10.2017 | Renewal fee patent year 03 | 27.10.2017 | Renewal fee patent year 04 | 27.10.2017 | Renewal fee patent year 05 | 27.10.2017 | Renewal fee patent year 06 | 02.01.2018 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2010011570 (LUNDBECK & CO AS H [DK], et al) [A] 1-15 * page 1, line 7 - line 9 ** claims 1, 18, 19, 21, 22 * | by applicant | - G. JAESCHKE et al., "mGlu5 receptor antagonists and their therapeutic potential", Expert Opin. Ther. Patents, (20080000), vol. 18, no. 2, doi:doi:10.1517/13543776.18.2.123, pages 123 - 142, XP002522663 DOI: http://dx.doi.org/10.1517/13543776.18.2.123 | - P. BACH et al., "Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications", Expert Opin. Ther. Patents, (20070000), vol. 17, no. 4, doi:doi:10.1517/13543776.17.4.371, pages 371 - 381, XP002549979 DOI: http://dx.doi.org/10.1517/13543776.17.4.371 | - S.M. BERGE et al., J. Pharm. Sci., (19770000), vol. 66, no. 1, page 2 | - G.S. PAULEKUHN et al., J. Med. Chem., (20070000), vol. 50, no. 26, pages 6665 - 6672 | - MAY, L.T., Annu. Rev. Pharmacol. Toxicol., (20070000), vol. 47, pages 1 - 51 | - J. A. O'BRIEN et al., Mol Pharmacol., (20030000), vol. 64, pages 731 - 740 | - Y. CHENG; W.H. PRUSOFF, Biochem. Pharmacol., (19730000), vol. 22, pages 3099 - 3108 | - K. NJUNG'E, K.; S.L. HANDLEY, Pharmacology, Biochemistry and Behavior, (19910000), vol. 38, pages 63 - 67 | - N.A. MOORE et al., Behavioural Pharmacology, (19940000), vol. 5, pages 196 - 202 | - VOGEL et al., Psychopharmacologia, (19710000), vol. 21, pages 1 - 7 | - WALKER; DAVIS, Biol. Psychiatry, (19970000), vol. 42, pages 461 - 471 | - S.E. FILE; P. SETH, European Journal of Pharmacology, (20030000), vol. 463, pages 35 - 53 | - S.M. KORTE; S.F. DE BOER, European Journal of Pharmacology, (20030000), vol. 463, pages 163 - 175 | - J.F. CRYAN et al., Neuroscience and Biobehavioral Reviews, (20050000), vol. 29, pages 547 - 569 | - D.H. OVERSTREET; G. GRIEBEL, Pharmacol Biochem Behav., (20050000), vol. 82, no. 1, pages 223 - 227 | - E. H. LEE et al., Chin. J. Physiol., (19920000), vol. 35, no. 4, pages 317 - 36 | - W. SCHULTZ, Prog. Neurobiol., (19820000), vol. 18, no. 2-3, pages 121 - 66 | - L. E. ANNETT et al., Exp. Neurol., (19940000), vol. 125, no. 2, pages 228 - 46 | - N. BREYSSE et al., J. Neurosci., (20020000), vol. 22, no. 13, pages 5669 - 5678 | - D. RYLANDER et al., J. Pharmacol. Exp. Ther., (20090000), vol. 330, no. 1, pages 227 - 235 | - L. CHEN et al., "Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons", Brain Res., (20090000), vol. 1286, pages 192 - 200, XP026422857 | - Q.J. YAN et al., Neuropharmacol., (20050000), vol. 49, pages 1053 - 1066 | - G. DOLEN et al., Neuron, (20070000), vol. 56, pages 955 - 962 | - R. DEPOORTERE et al., Neuropsychopharmacology, (20030000), vol. 28, no. 11, pages 1889 - 902 | - W. J. FREED et al., Neuropharmacology, (19840000), vol. 23, no. 2A, pages 175 - 81 | - F. SAMS-DODD, Neuropsychopharmacology, (19980000), vol. 19, no. 1, pages 18 - 25 | - Y. K. FUNG et al., Pharmacol. Biochem. Behav., (19860000), vol. 24, no. 1, pages 139 - 41 | - Y. K. FUNG et al., Steroids, (19870000), vol. 49, no. 4-5, pages 287 - 94 | - T. J. GOULD et al., Behav. Pharmacol., (20020000), vol. 13, no. 4, pages 287 - 94 | - A. O. HAMM et al., Brain, (20030000), vol. 126, pages 267 - 75 | - J. P. AGGLETON et al., Behav. Brain Res., (19960000), vol. 19, no. 2, pages 133 - 46 | - MORRIS, Learn. Motiv., (19810000), vol. 12, pages 239 - 260 | - B. BONTEMPI et al., Eur. J. Neurosci., (19960000), vol. 8, no. 11, pages 2348 - 60 | - M. DAY; M. GOOD, Neurobiol. Learn. Mem., (20050000), vol. 83, no. 1, pages 13 - 21 | - J. L. MUIR et al., Psychopharmacology (Berl), (19950000), vol. 118, no. 1, pages 82 - 92 | - ROBBINS et al., Ann. N. Y. Acad. Sci., (19980000), vol. 846, pages 222 - 37 | - KIM; CHUNG, Pain, (19920000), vol. 50, pages 355 - 363 | - WHEELER-ACETO et al., Psychopharmacology, (19910000), vol. 104, pages 35 - 44 | - H. Y. LIU et al., J. Neurosci. Res., (20020000), vol. 70, no. 2, pages 238 - 48 |